Teikoku Seiyaku Co. Ltd.

6 trials Commercial sponsor

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

0 Recruiting

7 Completed trials

1 Countries active

2 Unique IMPs

100% Results reported

Phase III

Phase I (Other)

Phase III: 2 Phase I (Other): 4

100%

7 of 7 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

ESFLURBIPROFEN 2

All trials

6 total

Open label study to investigate patch adhesion of an Esflurbiprofen-containing patch in healthy volunteers Ended

2025-523577-42-00 Phase I (Other) 1 country
Randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of an Esflurbiprofen Topical System (EFTS) vs. … Ended

2024-513063-45-00 Phase III 1 country ESFLURBIPROFEN
A Randomized, Four-Way Change-over Study to Evaluate the Effect of Moderate Heat, Occlusion, and Moderate Exercise on the Pharmacokinetics a… Ended

2024-513059-33-00 Phase I (Other) 1 country
An open-label, multi-centric trial to assess the safety and efficacy of an Esflurbiprofen Topical System (EFTS) in the local symptomatic and… Ended

2024-513064-26-00 Phase III 1 country ESFLURBIPROFEN
Characterisation of availability in the body of the active substance(s) of the newly developed patch Esflurbiprofen Topical System (EFTS) in… Ended

2024-513058-31-00 Phase I (Other) 1 country
Open label study to investigate patch adhesion of an Esflurbiprofen-containing patch in healthy volunteers Ended

2023-503609-12-00 Phase I (Other) 1 country

Showing 1–6 of 6 trials

← All sponsors A–Z